Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report

BACKGROUND: Myocarditis in patients treated with immune checkpoint inhibitors has previously been reported to be rare, though it has most likely been underreported owing to misdiagnosis in the absence of overt clinical presentation. Early detection and characterization of this potentially life-threa...

Descripción completa

Detalles Bibliográficos
Autores principales: Delombaerde, Danielle, Vervloet, Delphine, Berwouts, Dieter, Beckers, Roel, Prenen, Hans, Peeters, Marc, Gremonprez, Félix, Croes, Lieselot, Vulsteke, Christof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281161/
https://www.ncbi.nlm.nih.gov/pubmed/35831829
http://dx.doi.org/10.1186/s13256-022-03487-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281161/
https://www.ncbi.nlm.nih.gov/pubmed/35831829
http://dx.doi.org/10.1186/s13256-022-03487-4

Ejemplares similares